Axsome Therapeutics Inc (AXSM)
73.47
-0.74
(-1.00%)
USD |
NASDAQ |
May 31, 16:00
73.39
-0.08
(-0.11%)
After-Hours: 20:00
Axsome Therapeutics Gross Profit (TTM): 226.22M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 226.22M |
December 31, 2023 | 244.54M |
September 30, 2023 | 202.46M |
June 30, 2023 | 166.12M |
March 31, 2023 | 131.86M |
Date | Value |
---|---|
December 31, 2022 | 44.84M |
September 30, 2022 | 22.76M |
June 30, 2022 | 7.837M |
March 31, 2022 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Mar 2022
244.54M
Maximum
Dec 2023
116.29M
Average
131.86M
Median
Mar 2023
Gross Profit (TTM) Benchmarks
Krystal Biotech Inc | -- |
Pfizer Inc | 31.64B |
AbbVie Inc | 33.88B |
Viking Therapeutics Inc | -- |
Alnylam Pharmaceuticals Inc | 1.682B |